The pharmaceutical excipient segment within the pharmaceutical grade lactose market has witnessed substantial growth in recent years, driven by the increasing demand for high-quality ingredients in pharmaceutical formulations. Pharmaceutical-grade lactose, renowned for its compatibility with a wide range of active pharmaceutical ingredients (APIs), serves as a key excipient in tablet and capsule formulations. As pharmaceutical manufacturers strive to enhance drug stability, bioavailability, and patient acceptability, the demand for pharmaceutical-grade lactose as a formulation aid continues to surge. Moreover, stringent adherence to pharmaceutical quality standards ensures that pharmaceutical-grade lactose meets the regulatory requirements for use in various drug products, further bolstering its market presence. With the pharmaceutical industry's growing emphasis on product quality and efficacy, the pharmaceutical excipient segment of the pharmaceutical grade lactose market is poised for sustained growth, driven by ongoing advancements in formulation technologies and the increasing adoption of oral solid dosage forms.
Pharmaceutical grade lactose Market size was valued at USD 0.2 Billion in 2022. The pharmaceutical grade lactose industry is projected to grow from USD 0.21 Billion in 2023 to USD 0.29 Billion by 2032, exhibiting a compound annual growth rate (CAGR) of 4.40% during the forecast period (2023 - 2032).
Pharmaceutical grade lactose has been used as an excipient for more than a century. Because of its versatility, it is the backbone of many successful formulations. It is produced by concentrating whey or permeate (a co-product of whey protein concentrates production) to over-saturate the lactose, then removing, refining, drying, and milling the lactose crystals. Pharmaceutical grade lactose market is produced to meet rigid specifications, such as specific form and size distribution, monohydrate, crystalline, 40 mesh to 325 mesh, and a spray-dried mixture of crystalline and amorphous lactose for all applications.
Segment Analysis:
- Type:
- Crystalline Monohydrate Lactose
- α-Lactose monohydrate
- β-Lactose (anhydrous lactose)
- Inhalation Lactose
- Sieved
- Milled
- Granulated Lactose
- Spray Dried Lactose
- Others
- Application:
- Tablets manufacturing
- Direct compression
- Wet granulation
- Dry granulation
- Capsule manufacturing
- Capsules
- Sachets
- Others
- Others
Regional Analysis:
- Europe:
- Largest market.
- Presence of numerous manufacturers and manufacturing associations.
- Stringent norms and good manufacturing practices (GMP).
- Headquarters of key players like BASF Corporation, Merck KGaA, Kerry Inc., DFE Pharma.
- Standardization facilitated by International Pharmaceutical Excipients Council (IPEC) and EXCiPACT.
- Asia-Pacific:
- Second-largest market.
- Expected significant growth due to aging population and increasing cases of COPD.
- Significant increase in the elderly population projected.
- High prevalence of COPD in countries like China and India.
- Americas:
- Third-largest market.
- High prevalence of COPD contributes to market growth.
- Large number of diagnosed cases of chronic bronchitis and asthma in the US.
- COPD is a leading cause of death in the US.
- Middle East and Africa:
- Growing market due to high prevalence of COPD.
- Presence of distributors and subsidiaries.
- Companies like DFE Pharma and BASF Group have active presence in the region.
- Armor Pharma has local partners in nearly 20 countries in the region.
The pharmaceutical formulation aid sector, a crucial component of the pharmaceutical grade lactose market, plays a pivotal role in supporting drug development and manufacturing processes. Pharmaceutical-grade lactose serves as a versatile formulation aid, facilitating the production of various dosage forms, including tablets, capsules, and dry powder inhalers (DPIs). In DPI formulations, pharmaceutical-grade lactose acts as a carrier for active pharmaceutical ingredients (APIs), ensuring optimal dispersion and delivery to the respiratory tract. Furthermore, the exceptional powder flow properties and particle size distribution of pharmaceutical-grade lactose make it an ideal choice for DPI formulations, contributing to the development of effective inhalation therapies for respiratory diseases. As pharmaceutical companies continue to invest in respiratory drug development and personalized medicine, the demand for pharmaceutical-grade lactose as a formulation aid is expected to remain robust, driving market growth and innovation in drug delivery technologies tailored for pulmonary applications.
Key Players
The Global Pharmaceutical Grade Lactose Companies are Kerry Inc. (Ireland), DFE Pharma (Germany), Meggle Excipients Technology (Germany), Merck KGaA (Germany), Armor Pharma (France), ALPAVIT (Germany), BASF SE (Germany)
For more information visit at MarketResearchFuture
Other Trending Reports
